SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950123-10-115099
Filing Date
2010-12-21
Accepted
2010-12-20 17:32:12
Documents
3
Group Members
CAROLINA PHARMACEUTICALS HOLDINGS, LTD.CAROLINA PHARMACEUTICALS LTD.CRAIG A. COLLARD

Document Format Files

Seq Description Document Type Size
1 SC 13D/A b83819sc13dza.htm SC 13D/A 100189
2 EX-10.09 b83819exv10w09.htm EX-10.09 4793
3 EX-10.11 b83819exv10w11.htm EX-10.11 75274
  Complete submission text file 0000950123-10-115099.txt   182563
Mailing Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518
Business Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518 919-678-6611
CORNERSTONE THERAPEUTICS INC (Subject) CIK: 0001145404 (see all company filings)

IRS No.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79887 | Film No.: 101263776
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518
Business Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518 919-678-6611
Cornerstone BioPharma Holdings, Ltd. (Filed by) CIK: 0001434508 (see all company filings)

IRS No.: 201586225 | State of Incorp.: 1A | Fiscal Year End: 1231
Type: SC 13D/A